Saturday 17 October 2026
Export MRAI’s income statement to Excel — free account
Marpai, Inc.
MRAI Healthcare Healthcare Plans
Marpai, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.1 million, down 35.8% from fiscal 2024. In the quarter to June 2026, revenue fell 10.5%, EPS grew 35.7%, free cash flow fell 27.7% and total debt fell 20.3%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
3.13
0.06
−1.88%
Follow MRAI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.14 | 0.60 | 0.42 | 1.24 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
37.11 | (2.30) | (15.01) | (5.05) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.08 | 1.04 | 0.77 | 1.48 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(3.04) | (2.53) | (1.69) | (2.83) | |
EV/FCF |
(2.82) | (2.34) | (1.57) | (2.66) | |
Quick Ratio |
0.51 | 0.39 | 0.37 | 0.37 | |
Current Ratio |
0.53 | 0.40 | 0.38 | 0.38 | |
Net Debt/EBITDA |
0.41 | (1.62) | (2.49) | (1.18) | |
Debt/Assets |
73.87% | 154.37% | 134.27% | 111.31% | |
Debt/Equity |
(0.28) | (0.52) | (0.42) | (0.27) | |
Asset Turnover |
1.28 | 1.52 | 1.39 | 1.62 | |
Operating CF/Net income |
(0.18) | 0.85 | 0.15 | 0.89 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
(3.48) | (6.12) | (3.21) | (2.80) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
58.51% | 113.97% | 53.08% | 76.93% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
10.28% | 54.06% | 4.57% | 22.01% | |
Graham Net Nets |
(1.45) | (3.03) | (4.99) | (1.90) | |
Graham Number |
5.78 | 6.33 | 5.29 | 5.10 | |
Earnings Yield |
(56.62%) | (150.79%) | (300.00%) | (96.25%) | |
Free Cash Flow Yield |
(33.77%) | (73.38%) | (117.23%) | (44.86%) | |
Revenue per Share |
0.23 | 0.23 | 0.18 | 0.16 | |
Operating CF per Share |
0.04 | (0.27) | (0.02) | (0.16) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.04 | (0.27) | (0.02) | (0.16) | |
Cash per Share |
0.61 | 0.52 | 0.35 | 0.25 | |
Shareholders Equity per Share |
(1.93) | (1.87) | (1.43) | (1.50) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(1.93) | (1.87) | (1.43) | (1.50) | |
Free Cash Flow |
0.63 | (4.76) | (0.48) | (4.10) | |
Working Capital |
(10.70) | (15.36) | (16.72) | (14.54) | |
Net Current Asset Value |
(34.02) | (33.13) | (35.73) | (39.35) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1.49 | 1.19 | 1.09 | 1.78 | |
Average Payables |
4.09 | 3.39 | 4.32 | 4.69 | |
Average Assets |
16.18 | 11.89 | 12.32 | 10.26 | |
Average Common Equity |
(30.45) | (30.14) | (32.72) | (35.63) |
Columns are period end dates